HLS Therapeutics, Inc.

  • Market Cap: Small Cap
  • Industry: Pharmaceuticals & Biotechnology
  • ISIN: CA40390B1094
CAD
4.50
-0.48 (-9.64%)
  • Price Points
  • Score
  • Mojo Parameters
  • Total Return
  • News and Corporate Actions
  • Key factors
  • Shareholding
  • Financials
  • CompanyCV
stock-summaryHLS Therapeutics, Inc. VS Pharmaceuticals & Biotechnology
 
1D
-9.64%
-2.88%
1W
-10%
-3.21%
1M
-3.23%
-0.87%
YTD
14.5%
-0.39%
1Y
26.76%
18.99%
3Y
-68.02%
49.46%
5Y
-76.1%
80.47%
10Y
-76.1%
145.44%
  • Stock Absolute Returns
  • S&P/TSX 60Absolute Returns
stock-summaryPrice + Dividend
Total Returns (Price + Dividend) stock-summary
TimePeriod
Price Return
Dividend Return
Total Return
3 Months
12.78%
0%
12.78%
6 Months
31.96%
0%
31.96%
1 Year
26.76%
0%
26.76%
2 Years
-23.47%
0%
-23.47%
3 Years
-68.02%
0%
-68.02%
4 Years
-75.34%
0%
-75.34%
5 Years
-76.1%
0%
-76.1%

HLS Therapeutics, Inc. for the last several years.

stock-summaryRisk Adjusted Returns v/s S&P/TSX 60
Risk Adjusted Returns v/s stock-summary